This report provides exclusive insights into the COVID-19 impact on the Immunohematology Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Immunohematology Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Immunohematology Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on immunohematology market provides in-depth analysis of segments and sub-segments in global as well as regional immunohematology market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional immunohematology market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global immunohematology market. According to report, the global immunohematology market is projected to grow at a CAGR of 4.0% over the forecast period of 2018-2024.
Immunohematology is generally known as blood banking. Immunohematology assists in the screening of blood antigens, Rh factor, plasma, and white blood cell components in the donor blood. It is a branch of hematology that studies antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders.
Technological improvements in devices and reagents available for immunohematology testing and development of automated systems are some of the primary factors that are responsible for driving the immunohematology market. However high cost of maintenance and low awareness regarding the availability of these products in the developing and the underdeveloped economies may hamper the market growth. Initiatives to increase awareness of blood donations globally is expected to create lucrative opportunities for this market.
Geographically, North America held the largest market share in 2017, followed by Europe. The U.S drives the North America Immunohematology market. The wide base of diagnostic laboratories & blood banks and increase adoption of advanced technologies in hospitals and diagnostic centers of U.S are some of the major factors responsible for driving the growth of the North America market. Asia Pacific is expected to grow at the highest CAGR throughout the forecast period owing to an increase in disposable income in emerging countries like India and China and increasing awareness regarding immunohematology technologies.
The report on global immunohematology market covers segments such as product, application, and end-user. On the basis of product, the global immunohematology market is categorized into analyzers & systems and reagents. On the basis of application, the global immunohematology market is categorized into blood transfusion, pregnancy, organ transplantation and laboratory resolution of percentage problems. On the basis of end-user, the global immunohematology market is categorized into hospitals, diagnostic laboratories, and blood banks.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global immunohematology market such as Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA and Siemens Healthineers.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global immunohematology market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of immunohematology market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the immunohematology market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the immunohematology market to understand the present and future trends in this market and formulate their strategies accordingly.